Dipartimento di Ingegneria Elettrica

Contenuti del sito

Menu di navigazione - Torna all'inizio

Contenuto della pagina - Torna all'inizio

Ioana Alina Cristea

Piazza Botta 11, 27100, Pavia
Telefono0382 986452
Orari di ricevimentoSu appuntamento
InsegnamentiPsicologia Clinica (CDL Scienze e Tecniche Psicologiche) Applied Clinical Neuroscience (LM Psychology, Neuroscience and Human Sciences)


Meta-ricerca e sintesi della ricerca Open science Rigore e trasparenza in ricerca psicologica e biomedica L’efficacia di terapie psicologiche e farmacologiche per i disturbi mentali
CurriculumCristea CV
PubblicazioniLIST OF PUBLICATIONS 1. Peer-reviewed journal articles * indicates corresponding author In press 1. Fodor, L.A., Georgescu R., Cuijpers, P., Szamoskozi, S., David, D., Furukawa, T.A., Cristea, I.A.* (in press). Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis. The Lancet Psychiatry 2. Naudet, F., Braillon, A., Cristea, I. A., & Lexchin, J. (in press) Restoring the Bacloville trial: efficacy and harms. Addiction. doi:10.1111/add.15109 2020 3. Cristea, I. A.*, & Naudet, F. (2020). Is large-scale population screening coming to psychiatry? The Lancet Digital Health, 2(5), e210-e211. doi:10.1016/S2589-7500(20)30066-2 4. Naudet, F., & Cristea, I. A.* (2020). Approval of esketamine for treatment-resistant depression; Authors' reply. The Lancet Psychiatry, 7(3), 235-236. doi:10.1016/S2215-0366(20)30040-7 5. Moshe, I., Terhorst, Y., Cuijpers, P., Cristea, I., Pulkki-Råback, L., & Sander, L. (2020). Three Decades of Internet- and Computer-Based Interventions for the Treatment of Depression: Protocol for a Systematic Review and Meta-Analysis. JMIR Res Protoc, 9(3), e14860. doi:10.2196/14860 6. Cuijpers, P., Veen, S. C. v., Sijbrandij, M., Yoder, W., & Cristea, I. A. (2020). Eye movement desensitization and reprocessing for mental health problems: a systematic review and meta-analysis. Cognitive Behaviour Therapy, 1-16. doi:10.1080/16506073.2019.1703801 2019 7. Cristea, I. A.*, & Naudet, F. (2019). US Food and Drug Administration approval of esketamine and brexanolone. The Lancet Psychiatry, 6(12), 975-977. doi:10.1016/S2215-0366(19)30292-5 8. Cristea, I. A., Karyotaki, E., Hollon, S. D., Cuijpers, P., & Gentili, C. (2019). Biological markers evaluated in randomized trials of psychological treatments for depression: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 101, 32-44. doi:https://doi.org/10.1016/j.neubiorev.2019.03.022 9. Cristea, I. A., & Gentili, C. (2019). Publication Bias in Trials With and Without Null Findings. JAMA, 322(12), 1213-1214. doi:10.1001/jama.2019.11140 10. Nutu, D., Gentili, C., Naudet, F., & Cristea, I. A.* (2019). Open science practices in clinical psychology journals: An audit study. Journal of Abnormal Psychology, 128(6), 510-516. doi:10.1037/abn0000414 11. Georgescu, R., Fodor, L. A., Dobrean, A., & Cristea, I. A. *(2019). Psychological interventions using virtual reality for pain associated with medical procedures: a systematic review and meta-analysis. Psychological Medicine, 1-13. doi:10.1017/S0033291719001855 12. Stefan, S., Cristea, I. A., Szentagotai Tatar, A., & David, D. (2019). Cognitive-behavioral therapy (CBT) for generalized anxiety disorder: Contrasting various CBT approaches in a randomized clinical trial. Journal of Clinical Psychology, 75(7), 1188-1202. doi:10.1002/jclp.22779 13. Cuijpers, P., Quero, S., Papola, D., Cristea, I. A., & Karyotaki, E. (2019). Care-as-usual control groups across different settings in randomized trials on psychotherapy for adult depression: a meta-analysis. Psychological Medicine, 1-11. doi:10.1017/S0033291719003581 14. Cristea, I. A.*, & Naudet, F. (2019). Increase value and reduce waste in research on psychological therapies. Behaviour Research and Therapy, 123, 103479. doi:https://doi.org/10.1016/j.brat.2019.103479 15. Cristea, I. A., Cahan, E. M., & Ioannidis, J. P. A. (2019). Stealth research: Lack of peer-reviewed evidence from healthcare unicorns. European Journal of Clinical Investigation, 49(4), e13072. doi:10.1111/eci.13072 16. Cristea, I. A.* (2019). The waiting list is an inadequate benchmark for estimating the effectiveness of psychotherapy for depression. Epidemiology and Psychiatric Sciences, 28(3), 278-279. doi:10.1017/S2045796018000665 17. Braillon, A., Naudet, F., Cristea, I. A., & Lexchin, J. (2019). Baclofen and Alcohol Use Disorders: Breakthrough or Great White Elephant? Alcohol and Alcoholism, 55(1), 49-50. doi:10.1093/alcalc/agz083 18. Cosgrove, L., Cristea, I. A., Shaughnessy, A. F., Mintzes, B., & Naudet, F. (2019). Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media. BMJ Evidence-Based Medicine, 24(6), 231-238. doi:10.1136/bmjebm-2019-111204 19. Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Hollon, S. D. (2019). Component studies of psychological treatments of adult depression: A systematic review and meta-analysis. Psychother Res, 29(1), 15-29. doi:10.1080/10503307.2017.1395922 20. Yoder, W. R., Karyotaki, E., Cristea, I.-A., van Duin, D., & Cuijpers, P. (2019). Researcher allegiance in research on psychosocial interventions: meta-research study protocol and pilot study. BMJ Open, 9(2), bmjopen-2018-024622. doi:10.1136/bmjopen-2018-024622 21. Robe, A., Dobrean, A., Cristea, I. A., Pasarelu, C. R., & Predescu, E. (2019). Attention-deficit/hyperactivity disorder and task-related heart rate variability: A systematic review and meta-analysis. Neurosci Biobehav Rev, 99, 11-22. doi:10.1016/j.neubiorev.2019.01.022 22. Chekroud, A. M., & Cristea, I. A.* (2019). Repetitive transcranial magnetic stimulation for depression. Lancet, 393(10170), 403. doi:10.1016/s0140-6736(18)32760-0 2018 23. Janiaud, P., Cristea, I. A., & Ioannidis, J. P. A. (2018). Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview. Intensive Care Medicine, 44(10), 1613-1627. doi:10.1007/s00134-018-5325-3 24. Cristea, I. A., & Ioannidis, J. P. A. (2018). Disclosures Can Always Be Improved-Reply. JAMA Psychiatry, 75(12), 1303-1304. doi:10.1001/jamapsychiatry.2018.2785 25. Cristea, I.A., & Ioannidis, J.P.A. (2018). Improving disclosure of financial conflicts of interest for research on psychosocial interventions. JAMA Psychiatry 75(6), 541-542, doi:10.1001/jamapsychiatry.2018.0382 26. Cristea, I.A.* (2018) Experimental psychopathology should not be examined with rose-tinted glasses. Lancet Psychiatry 5(6), 465-466. 27. Cristea, I.A., & Ioannidis, J.P.A. (2018). P values in display items are ubiquitous and almost invariably significant: A survey of top science journals. PLoS One 13(5), e0197440. https://doi.org/10.1371/journal.pone.0197440 28. Fodor, L. A., Coteț, C. D., Cuijpers, P., Szamoskozi, Ș., David, D., & Cristea, I. A.* (2018). The effectiveness of virtual reality based interventions for symptoms of anxiety and depression: A meta-analysis. Scientific Reports, 8(1),10323. doi:10.1038/s41598-018-28113-6 29. Cristea, I. A.*, Kok, R. N., & Cuijpers, P. (2018). Persistent Double Standards in Evaluating the Effectiveness of Cognitive Bias Modification: A Commentary on Wiers et al. (2018). Journal of Studies on Alcohol and Drugs, 79(3), 344-345. 30. Moher, D., Naudet, F., Cristea, I. A., Miedema, F., Ioannidis, J. P. A., & Goodman, S. N. (2018). Assessing scientists for hiring, promotion, and tenure. PLOS Biology, 16(3), e2004089. doi:10.1371/journal.pbio.2004089 31. Naudet, F., Sakarovitch, C., Janiaud, P., Cristea, I.A., Fanelli, D., Moher, D., & Ioannidis, J. P. A. (2018). Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine. The BMJ, 360. doi:10.1136/bmj.k400 32. Cristea, I.A., Naudet, A.F. (2018). Defending psychiatry or defending the trivial effects of therapeutic interventions? A citation content analysis of an influential paper. Epidemiology and Psychiatric Sciences 27(3), 230-239, https://doi.org/10.1017/S2045796017000750 33. David, D., Cristea, I.A., & Hofmann, S. G. (2018). Why Cognitive Behavioral Therapy Is the Current Gold Standard of Psychotherapy. Frontiers in Psychiatry, 9, 4. doi:10.3389/fpsyt.2018.00004 34. Cristea, I.A. (2018) Author reply. The British Journal of Psychiatry 212(4), p.247 https://doi.org/10.1192/bjp.2018.43 2017 35. Cristea, I.A*., Gentili, C., Coteț, C., Palomba, D., Barbui, C., & Cuijpers, P. (2017) Efficacy of psychotherapies for Borderline Personality Disorder: A systematic reviews and meta-analysis, JAMA Psychiatry, 74(4), 319-328, 10.1001/jamapsychiatry.2016.4287 36. Cristea, I.A.*, Stefan, S., Karyotaki, E., David, D., Hollon, S., Cuijpers, P. (2017). The effects of cognitive behavioral therapy are not systematically falling: a revision of Johnsen & Friborg (2015). Psychological Bulletin 143(3), 326-340 http://dx.doi.org/10.1037/bul0000062 37. Cristea, I. A., Naudet, F., Shanks, D. R., & Hardwicke, T. E. (2017). Post-retrieval Tetris should not be likened to a 'cognitive vaccine'. Molecular Psychiatry. doi:10.1038/mp.2017.222 (conception, write 1st draft) 38. Cristea, I. A.*, Cuijpers, P., & Naudet, F. (2017). Equivalence of Psychodynamic Therapy to Other Established Treatments: Limited Supporting Evidence and Clinical Relevance. American Journal of Psychiatry, 174(11), 1122-1123. doi:10.1176/appi.ajp.2017.17050592 39. Cristea, I.A*., Barbui, C., & Cuijpers, P. (2017). Reviews and meta-analyses of psychotherapy efficacy for borderline personality disorder—reply. JAMA Psychiatry, 74(8), 854-855. doi:10.1001/jamapsychiatry.2017.1403 40. Cuijpers, P., Weitz, E., Cristea, I.A., & Twisk, J. (2017). Pre-post effect sizes should be avoided in meta-analyses. Epidemiology and Psychiatric Sciences, 26(4), 364-368. doi:10.1017/S2045796016000809 41. Gentili, C., Cristea, I.A., Ricciardi, E., Vanello, N., Popita, C., David, D., & Pietrini, P. (2017). Not in one metric: Neuroticism modulates different resting state metrics within distinctive brain regions. Behavioural Brain Research, 327, 34-43. doi:10.1016/j.bbr.2017.03.031 42. Cristea, I.A*., Gentili, C., Pietrini, P., & Cuijpers, P. (2017). Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis. The British Journal of Psychiatry, 210(1), 16–23. https://doi.org/10.1192/bjp.bp.115.179275 43. Cristea, I.A*., Gentili, C., Pietrini, P., & Cuijpers, P. (2017). Is investigator background related to outcome in head to head trials of psychotherapy and pharmacotherapy for adult depression? A systematic review and meta-analysis. PLoS One, 12 (2), e0171654 http://dx.doi.org/10.1371/journal.pone.0171654 44. Cristea, I. A*., Kok, R. N., & Cuijpers, P. (2017). Invited commentary on ... Confusing procedures with process in cognitive bias modification research. The British Journal of Psychiatry, 211(5), 272-273. doi:10.1192/bjp.bp.117.200972 45. Cristea, I.A., Cuijpers, P. (2017). In the pursuit of truth, we should not prioritize correlational over causal evidence. Psychotherapy Research, 27(1), 36-37 http://dx.doi.org/10.1080/10503307.2016.1249434 2. Books and book chapters 1. Cuijpers, P., Cristea, I.A. Systematic Reviews in Mental Health (2019). In Dimidjian, S. (editor) “Evidence-Based Practice in Action: Bridging Clinical Science and Intervention”. Guilford Press 2. David, D., Cristea, I.A., Beck, A.T., (2018). Varieties of psychotherapies for major depressive disorder in adults: An evidence-based evaluation. In David, D., Lynn, S., Montgomery, G. (editors) "Evidence-based psychotherapy: The state of the science and practice". Wiley Blackwell
CollaborazioniProf. John Ioannidis, C.F. Rehnborg Chair in Disease Prevention at Stanford University, Professor of Medicine, Professor of Health Research and Policy, Department of Medicine, Stanford University, USA Prof. Pim Cuijpers, Professor of Clinical Psychology, head of department, Department of Clinical, Neuro and Developmental Psychology, Vrije Universiteit, Amsterdam, The Netherlands Prof. Florian Naudet, Associate professor of Therapeutics, Clinical Investigation Center (INSERM 1414) and Adult Psychiatry Department, University of Rennes 1, Rennes, France Prof. Corrado Barbui, Professor of Psychiatry, Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy Prof. Toshiaki Furukawa, Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan Prof. Daniel David, Department of Clinical Psychology and Psychotherapy, Babes-Bolyai University, Cluj Napoca, Romania Prof. Steven Goodman, Professor of Medicine and of Health Research & Policy, Department of Medicine, Stanford University, USA Prof. Pietro Pietrini, Professor of Clinical Biochemistry and Molecular Biology, Director, Scuola IMT Alti Studi Lucca, Lucca, Italy Prof. Steven D. Hollon, Professor of Psychology and Human Development, Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA